We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
-9.26%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$19.3B
AUM Growth
-$2.78B
Cap. Flow
-$399M
Cap. Flow %
-2.06%
Top 10 Hldgs %
19.12%
Holding
149
New
4
Increased
70
Reduced
65
Closed
8

Top Buys

Rank Stock Value
1
IEX icon
IDEX
IEX
+$65M
2
DXCM icon
DexCom
DXCM
+$63M
3
ASAN icon
Asana
ASAN
+$62.2M
4
ROK icon
Rockwell Automation
ROK
+$53.5M
5
WSFS icon
WSFS Financial
WSFS
+$51.3M

Top Sells

Rank Stock Value
1
HSY icon
Hershey
HSY
+$171M
2
STE icon
Steris
STE
+$111M
3
PLAN
Anaplan, Inc.
PLAN
+$98.1M
4
CRNC icon
Cerence
CRNC
+$86.6M
5
TMX
Terminix Global Holdings, Inc.
TMX
+$82.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Technology 22.95%
3 Industrials 17.41%
4 Financials 13.37%
5 Consumer Staples 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECH icon
26
Bio-Techne
TECH
$11.3B
$215M 1.12%
1,989,820
+294,020
+17% +$30.3M
IEX icon
27
IDEX
IEX
$16.4B
$215M 1.11%
1,122,850
+320,220
+40% +$65M
PB icon
28
Prosperity Bancshares
PB
$8.59B
$207M 1.07%
2,990,485
-37,582
-1% -$2.77M
AQUA
29
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$205M 1.06%
4,368,880
-427,265
-9% -$18.2M
LESL icon
30
Leslie's
LESL
$4.61M
$205M 1.06%
528,961
+3,365
+0.6% +$1.4M
CNMD icon
31
CONMED
CNMD
$1.39B
$204M 1.06%
1,373,005
-121,630
-8% -$17M
AKAM icon
32
Akamai
AKAM
$15.2B
$203M 1.05%
1,698,320
+377,760
+29% +$42.4M
VEEV icon
33
Veeva Systems
VEEV
$43B
$202M 1.05%
951,807
+210,653
+28% +$45.7M
NDSN icon
34
Nordson
NDSN
$17.2B
$202M 1.04%
888,335
+8,082
+0.9% +$1.86M
CLX icon
35
Clorox
CLX
$10.8B
$201M 1.04%
1,443,225
+12,554
+0.9% +$1.92M
JBTM
36
JBT Marel
JBTM
$5.8B
$198M 1.02%
1,668,390
-84,470
-5% -$10.8M
CSGP icon
37
CoStar Group
CSGP
$12.8B
$191M 0.99%
2,871,545
+706,650
+33% +$46.9M
VRSK icon
38
Verisk Analytics
VRSK
$24.3B
$189M 0.98%
881,375
+181,727
+26% +$35.8M
NTRS icon
39
Northern Trust
NTRS
$33.2B
$188M 0.97%
1,611,565
+19,019
+1% +$2.25M
MSA icon
40
Mine Safety
MSA
$6.98B
$184M 0.95%
1,386,620
-22,650
-2% -$3.13M
INSP icon
41
Inspire Medical Systems
INSP
$2.15B
$180M 0.93%
702,655
+29,930
+4% +$6.84M
TNDM icon
42
Tandem Diabetes Care
TNDM
$1.17B
$179M 0.93%
1,541,325
+54,812
+4% +$6.4M
COO icon
43
Cooper Companies
COO
$10.3B
$179M 0.93%
1,715,480
+15,132
+0.9% +$1.52M
OKTA icon
44
Okta
OKTA
$32.6B
$179M 0.93%
1,183,735
+248,581
+27% +$44.6M
SNPS icon
45
Synopsys
SNPS
$73.1B
$177M 0.92%
532,585
+43,465
+9% +$13.6M
HRL icon
46
Hormel Foods
HRL
$11.5B
$175M 0.91%
3,403,365
+31,440
+0.9% +$1.54M
SIVB
47
DELISTED
SVB Financial Group
SIVB
$173M 0.9%
309,755
+6,374
+2% +$3.87M
SMPL icon
48
Simply Good Foods
SMPL
$879M
$173M 0.9%
4,562,799
-823,935
-15% -$30.7M
NEWR
49
DELISTED
New Relic, Inc.
NEWR
$169M 0.88%
2,527,630
-400,835
-14% -$32.8M
TSCO icon
50
Tractor Supply
TSCO
$17.6B
$160M 0.83%
3,422,400
+19,375
+0.6% +$857K
1
2
3 4 5

Similar funds

NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $3.89B AUM
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $3.9B AUM
AC
Anther Capital Hong Kong $3.91B AUM

Champlain Investment Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Champlain Investment Partners held 149 positions worth $19.3B, down 13% from $22.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners's Q1 2022 filing shows 4 new, 70 increased, 65 reduced and 8 closed positions. Its largest new stake was DexCom: 576,320 shares worth $73.7M. The largest sale was Hershey, an estimated $171M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q1 2022 buy was DexCom: 576,320 shares worth $73.7M.
  • Champlain Investment Partners added most to IDEX in Q1 2022, an estimated $65M increase.
  • Champlain Investment Partners's biggest Q1 2022 reduction was Steris, cutting an estimated $111M.
  • Champlain Investment Partners fully exited Hershey in Q1 2022, selling an estimated $171M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $19.3B portfolio in Q1 2022.
  • Champlain Investment Partners opened 4 new positions and closed 8 in Q1 2022.
  • Champlain Investment Partners's portfolio value fell 13% quarter-over-quarter to $19.3B.

Based on Champlain Investment Partners's 13F filing for Q1 2022, filed 12 May 2022.